1. Home
  2. IMMP vs NMG Comparison

IMMP vs NMG Comparison

Compare IMMP & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • NMG
  • Stock Information
  • Founded
  • IMMP 1987
  • NMG 2011
  • Country
  • IMMP Australia
  • NMG Canada
  • Employees
  • IMMP N/A
  • NMG N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • NMG Other Metals and Minerals
  • Sector
  • IMMP Health Care
  • NMG Basic Materials
  • Exchange
  • IMMP Nasdaq
  • NMG Nasdaq
  • Market Cap
  • IMMP 244.5M
  • NMG 249.7M
  • IPO Year
  • IMMP N/A
  • NMG 2017
  • Fundamental
  • Price
  • IMMP $1.80
  • NMG $1.77
  • Analyst Decision
  • IMMP Buy
  • NMG Strong Buy
  • Analyst Count
  • IMMP 1
  • NMG 2
  • Target Price
  • IMMP $7.00
  • NMG $2.58
  • AVG Volume (30 Days)
  • IMMP 69.1K
  • NMG 177.1K
  • Earning Date
  • IMMP 02-27-2025
  • NMG 08-13-2025
  • Dividend Yield
  • IMMP N/A
  • NMG N/A
  • EPS Growth
  • IMMP N/A
  • NMG N/A
  • EPS
  • IMMP N/A
  • NMG N/A
  • Revenue
  • IMMP $3,019,249.00
  • NMG N/A
  • Revenue This Year
  • IMMP $50.37
  • NMG N/A
  • Revenue Next Year
  • IMMP N/A
  • NMG N/A
  • P/E Ratio
  • IMMP N/A
  • NMG N/A
  • Revenue Growth
  • IMMP 24.11
  • NMG N/A
  • 52 Week Low
  • IMMP $1.32
  • NMG $1.22
  • 52 Week High
  • IMMP $2.72
  • NMG $2.58
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 59.33
  • NMG 43.71
  • Support Level
  • IMMP $1.60
  • NMG $1.73
  • Resistance Level
  • IMMP $1.83
  • NMG $2.50
  • Average True Range (ATR)
  • IMMP 0.05
  • NMG 0.18
  • MACD
  • IMMP 0.02
  • NMG -0.03
  • Stochastic Oscillator
  • IMMP 84.78
  • NMG 9.88

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

Share on Social Networks: